Neoantigen Targeted Therapies Global Market Report 2025

Global Neoantigen Targeted Therapies Market Report 2024

Neoantigen Targeted Therapies Global Market Report 2025 – By Type (Monotherapy, Combination Therapy), By Immunotherapy Type (DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based Therapies), By Target Disease Indication (Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Bone Cancer, Gynecological Cancer), By Route of Administration (Intradermal, Intravenous, Subcutaneous), By Application (Medical Research Institution, Hospital, and Clinic, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

Name: Neoantigen Targeted Therapies Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Neoantigen Targeted Therapies Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Neoantigen Targeted Therapies Global Market Report 2025

Proud Members Of

Neoantigen Targeted Therapies Market Definition

Neoantigen-targeted therapies are a type of precision medicine that concentrates on neoantigens in cancer cells. Neoantigens are distinct antigens that are derived from genetic abnormalities or modifications present in cancer cells. It is used to harness the body's immune system to recognize and attack cancer cells specifically by targeting these neoantigens.

The main types of neoantigens targeted therapies are monotherapy and combination therapy. The term monotherapy refers to a medical approach to treating a problem or disease that uses only one medicine or therapy. The various immunotherapy types include DNA or RNA-based vaccines, protein-based vaccines, Dendritic Cell Vaccines, and TIL-based therapies that target various disease indications such as colorectal cancer, renal cell carcinoma, non-small cell lung cancer, bone cancer, and gynecological cancer. The various routes of administration include intradermal, intravenous, and subcutaneous, and the various applications include medical research institutions, hospitals, clinics, and others.

Neoantigen Targeted Therapies Market Segmentation

The neoantigen targeted therapies market covered in this report is segmented –

1) By Type: Monotherapy, Combination Therapy

2) By Immunotherapy Type: DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based Therapies

3) By Target Disease Indication: Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Bone Cancer, Gynecological Cancer

4) By Route Of Administration: Intradermal, Intravenous, Subcutaneous

5) By Application: Medical Research Institution, Hospital, And Clinic, Other Applications

Subsegments:

1) By Monotherapy: Individual Neoantigen-Targeted Treatments

2) By Combination Therapy: Neoantigen-Targeted Therapies Combined With Other Immunotherapies, Neoantigen-Targeted Therapies Combined With Chemotherapy, Neoantigen-Targeted Therapies Combined With Targeted Therapies

Neoantigen Targeted Therapies Market Size and growth rate 2025 to 2029: Graph

Neoantigen Targeted Therapies Market Size 2025 And Growth Rate

The neoantigen targeted therapies market size has grown exponentially in recent years. It will grow from $3.4 billion in 2024 to $4.72 billion in 2025 at a compound annual growth rate (CAGR) of 38.7%. The growth in the historic period can be attributed to advancements in genomic sequencing, immunotherapy evolution, understanding tumor immunology, clinical success of checkpoint inhibitors, molecular profiling advancements

Neoantigen Targeted Therapies Market Growth Forecast

The neoantigen targeted therapies market size is expected to see exponential growth in the next few years. It will grow to $16.01 billion in 2029 at a compound annual growth rate (CAGR) of 35.7%. The growth in the forecast period can be attributed to advancements in bioinformatics, precision medicine expansion, neoantigen vaccine development, therapeutic combination strategies, biomarker validation. Major trends in the forecast period include neoantigen resistance management, neoantigen-primed adoptive cell therapies, neoantigen-based combinatorial therapies, integration of real-world data, enhanced predictive models.

Book your 30 minutes free consultation with our research experts

Neoantigen Targeted Therapies Market Driver: Rising Incidence Of Cancer Cases Drives Growth In The Neoantigen Targeted Therapies Market

The increasing incidence of cancer cases is expected to propel the growth of the neoantigen targeted therapies market going forward. The incidence of cancer refers to the number of new cases of cancer in a specific population for a given period. Neoantigen-targeted therapies are often used in combination to treat different types of cancer. For instance, the American Cancer Society (ACS), a US-based voluntary health organization, in 2022, the United States had 1.9 million new cancer cases, representing a significant increase compared to previous years. Furthermore, in 2022, in the US, approximately 609,360 deaths were attributed to cancer, emphasizing the profound severity and impact of this disease on individuals and their families. Therefore, the increasing incidence of cancer cases is driving the growth of the neoantigen targeted therapies market.

Neoantigen Targeted Therapies Market Driver: Surge Of Precision Oncology Propels Growth In The Neoantigen Targeted Therapies Market

The rising precision oncology is expected to propel the growth of the neoantigen targeted therapies market going forward. Precision oncology is an approach to cancer treatment that utilizes detailed genetic and molecular information about a patient's tumor to guide the selection of targeted therapies. Precision oncology uses neoantigen-targeted therapies by leveraging advanced genomic analysis to identify unique neoantigens expressed by an individual's cancer cells. The utilization of neoantigen-targeted therapies in precision oncology reflects a strategy to address the specific genetic makeup of each patient's tumor, offering a more personalized and effective treatment option. For instance, in March 2024, according to the Precision Oncology Clinical Trials & Statistics 2024 report published by Novotech, an Australia-based full-service clinical contract research organization involved in the development of innovative therapeutics across all phases, by November 2023, twelve treatments had received FDA approval for specific biomarker-selected indications, with six of these also included in the NCCN guidelines. By the year's end, 43% of the 217 FDA-approved oncology therapies were classified as precision oncology, and 78 of these therapies featured DNA or NGS-detectable biomarkers, highlighting the growing prominence of biomarker-driven treatments in cancer care. Therefore, rising precision oncology is driving the growth of the neoantigen-targeted therapies market.

Global Neoantigen Targeted Therapies Market Major Players

Major companies operating in the neoantigen targeted therapies market include F. Hoffmann-La Roche AG, Merck and Co. Inc., Bristol Myers Squibb Company, Eli Lilly and Company, Kite Pharma Inc., Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Bavarian Nordic Inc., Advaxis Inc., Immatics NV, Precision Biologics Inc., Iovance Biotherapeutics Inc., Agenus Inc., Achilles Therapeutics Plc, Medigene AG, Gritstone Bio Inc., SQZ Biotechnologies Company, Aduro BioTech Inc., Inovio Pharmaceuticals Inc., Gradalis Inc., EpiVax Inc., ISA Pharmaceuticals BV, Vaxon Biotech SA, Ziopharm Oncology, Genocea Biosciences Inc., Cellular Biomedicine Group Inc., Immunovaccine Inc.

Global Neoantigen Targeted Therapies Market Trend: Strategic Partnerships Drive Advancements In Personalized Neoantigen Targeted Cancer Therapies

Major companies operating in the neoantigen targeted therapies market are adopting a strategic partnership approach to personalize cancer therapies to overcome the challenges of existing immunotherapy in the treatment of solid tumors. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in January 2023, BioNTech SE, a Germany-based biotechnology company partnered with the Government of the United Kingdom, a UK-based organization to advance personalized mRNA cancer immunotherapies. This collaboration aims to deliver tailored treatments to as many as 10,000 patients by 2030 and covers several critical areas, including the development of cancer immunotherapies, research on infectious disease vaccines, and the creation of a research and development hub in Cambridge. The initiative will leverage the UK’s clinical trial infrastructure and health data resources to improve patient recruitment and select trial sites for BioNTech’s mRNA treatments. The company plans to initiate its first clinical trials in the UK later this year, focusing on cancer vaccines that could potentially integrate into standard treatment protocols if proven effective.

Global Neoantigen Targeted Therapies Market Trend: Strategic Partnerships In Neoantigen Targeted Therapies To Personalize Cancer Treatment And Enhance Immunotherapy Effectiveness

Major companies operating in the neoantigen targeted therapies market are adopting a strategic partnership approach to personalize neoantigen vaccines and monoclonal antibody drugs to overcome the challenges of existing immunotherapy in the treatment of solid tumors. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in April 2023, Moderna, Inc., a US-based pharmaceutical and biotechnology company collaborated with Merck & Co., Inc. a US-based pharmaceutical company that launched mRNA-4157 (V940). It is an investigational individualized neoantigen therapy (INT) designed to generate a tailored antitumor immune response based on the unique mutational signature of a patient's tumor. mRNA-4157 (V940) works by encoding up to 34 neoantigens to stimulate T cell responses, enhancing the body’s ability to target and destroy tumor cells when combined with Merck’s immunotherapy KEYTRUDA. This combination aims to improve recurrence-free survival in patients with high-risk resected melanoma.

Neoantigen Targeted Therapies Market Merger And Acquisition: Astrazeneca's Strategic Acquisition Of Neogene Therapeutics To Boost TCR Therapy Development

In January 2023, AstraZeneca plc, a UK-based pharmaceutical industry company acquired Neogene Therapeutics Inc. for $200 million. This acquisition aims to bolster AstraZeneca’s oncology portfolio, focusing on the development of transformative T-cell receptor (TCR) therapies targeting neoantigens in solid tumors. Neogene's expertise in next-generation TCR-T therapies is expected to complement AstraZeneca's existing capabilities in the oncology space, enabling the company to further its advancements in cancer treatments. Neogene Therapeutics Inc. is a US-based biotechnology company that provides neoantigen-targeted therapies.

Regional Outlook For The Global Neoantigen Targeted Therapies Market

North America was the largest region in the neoantigen targeted therapies market in 2024. The regions covered in the neoantigen targeted therapies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neoantigen targeted therapies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Neoantigen Targeted Therapies Market?

The neoantigen targeted therapies market consists of revenues earned by entities by providing services such as the identification and characterization of neoantigens in individual patients, the selection and administration of the appropriate therapy, and the monitoring of patients' responses. The market value includes the value of related goods sold by the service provider or included within the service offering. Neoantigen targeted therapies also include the sale of neoantigen-based cancer vaccines and genetically modified T cells. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Neoantigen Targeted Therapies Industry?

The neoantigen targeted therapies market research report is one of a series of new reports from The Business Research Company that provides neoantigen targeted therapies market statistics, including the neoantigen targeted therapies industry global market size, regional shares, competitors with a neoantigen targeted therapies market share, detailed neoantigen targeted therapies market segments, market trends, and opportunities, and any further data you may need to thrive in the neoantigen targeted therapies industry. This neoantigen targeted therapies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Neoantigen Targeted Therapies Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$4.72 billion
Revenue Forecast In 2034	$16.01 billion
Growth Rate	CAGR of 35.7% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Type: Monotherapy, Combination Therapy 2) By Immunotherapy Type: DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based Therapies 3) By Target Disease Indication: Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Bone Cancer, Gynecological Cancer 4) By Route Of Administration: Intradermal, Intravenous, Subcutaneous 5) By Application: Medical Research Institution, Hospital, And Clinic, Other Applications Subsegments: 1) By Monotherapy: Individual Neoantigen-Targeted Treatments 2) By Combination Therapy: Neoantigen-Targeted Therapies Combined With Other Immunotherapies, Neoantigen-Targeted Therapies Combined With Chemotherapy, Neoantigen-Targeted Therapies Combined With Targeted Therapies
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	F. Hoffmann-La Roche AG, Merck and Co. Inc., Bristol Myers Squibb Company, Eli Lilly and Company, Kite Pharma Inc., Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Bavarian Nordic Inc., Advaxis Inc., Immatics NV, Precision Biologics Inc., Iovance Biotherapeutics Inc., Agenus Inc., Achilles Therapeutics Plc, Medigene AG, Gritstone Bio Inc., SQZ Biotechnologies Company, Aduro BioTech Inc., Inovio Pharmaceuticals Inc., Gradalis Inc., EpiVax Inc., ISA Pharmaceuticals BV, Vaxon Biotech SA, Ziopharm Oncology, Genocea Biosciences Inc., Cellular Biomedicine Group Inc., Immunovaccine Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Neoantigen Targeted Therapies Market Characteristics

3. Neoantigen Targeted Therapies Market Trends And Strategies

4. Neoantigen Targeted Therapies Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Neoantigen Targeted Therapies Growth Analysis And Strategic Analysis Framework

5.1. Global Neoantigen Targeted Therapies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Neoantigen Targeted Therapies Market Growth Rate Analysis

5.4. Global Neoantigen Targeted Therapies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Neoantigen Targeted Therapies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Neoantigen Targeted Therapies Total Addressable Market (TAM)

6. Neoantigen Targeted Therapies Market Segmentation

6.1. Global Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monotherapy

Combination Therapy

6.2. Global Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

DNA Or RNA-Based Vaccines

Protein-Based Vaccines

Dendritic Cell Vaccines

TIL-Based Therapies

6.3. Global Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Colorectal Cancer

Renal Cell Carcinoma

Non-Small Cell Lung Cancer

Bone Cancer

Gynecological Cancer

6.4. Global Neoantigen Targeted Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intradermal

Intravenous

Subcutaneous

6.5. Global Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Medical Research Institution

Hospital And Clinic

Other Applications

6.6. Global Neoantigen Targeted Therapies Market, Sub-Segmentation Of Monotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Individual Neoantigen-Targeted Treatments

6.7. Global Neoantigen Targeted Therapies Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Neoantigen-Targeted Therapies Combined With Other Immunotherapies

Neoantigen-Targeted Therapies Combined With Chemotherapy

Neoantigen-Targeted Therapies Combined With Targeted Therapies

7. Neoantigen Targeted Therapies Market Regional And Country Analysis

7.1. Global Neoantigen Targeted Therapies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Neoantigen Targeted Therapies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neoantigen Targeted Therapies Market

8.1. Asia-Pacific Neoantigen Targeted Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neoantigen Targeted Therapies Market

9.1. China Neoantigen Targeted Therapies Market Overview

9.2. China Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neoantigen Targeted Therapies Market

10.1. India Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neoantigen Targeted Therapies Market

11.1. Japan Neoantigen Targeted Therapies Market Overview

11.2. Japan Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neoantigen Targeted Therapies Market

12.1. Australia Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neoantigen Targeted Therapies Market

13.1. Indonesia Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neoantigen Targeted Therapies Market

14.1. South Korea Neoantigen Targeted Therapies Market Overview

14.2. South Korea Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neoantigen Targeted Therapies Market

15.1. Western Europe Neoantigen Targeted Therapies Market Overview

15.2. Western Europe Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neoantigen Targeted Therapies Market

16.1. UK Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neoantigen Targeted Therapies Market

17.1. Germany Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neoantigen Targeted Therapies Market

18.1. France Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neoantigen Targeted Therapies Market

19.1. Italy Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neoantigen Targeted Therapies Market

20.1. Spain Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neoantigen Targeted Therapies Market

21.1. Eastern Europe Neoantigen Targeted Therapies Market Overview

21.2. Eastern Europe Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neoantigen Targeted Therapies Market

22.1. Russia Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neoantigen Targeted Therapies Market

23.1. North America Neoantigen Targeted Therapies Market Overview

23.2. North America Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neoantigen Targeted Therapies Market

24.1. USA Neoantigen Targeted Therapies Market Overview

24.2. USA Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neoantigen Targeted Therapies Market

25.1. Canada Neoantigen Targeted Therapies Market Overview

25.2. Canada Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neoantigen Targeted Therapies Market

26.1. South America Neoantigen Targeted Therapies Market Overview

26.2. South America Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neoantigen Targeted Therapies Market

27.1. Brazil Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neoantigen Targeted Therapies Market

28.1. Middle East Neoantigen Targeted Therapies Market Overview

28.2. Middle East Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neoantigen Targeted Therapies Market

29.1. Africa Neoantigen Targeted Therapies Market Overview

29.2. Africa Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neoantigen Targeted Therapies Market Competitive Landscape And Company Profiles

30.1. Neoantigen Targeted Therapies Market Competitive Landscape

30.2. Neoantigen Targeted Therapies Market Company Profiles

30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Kite Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Neoantigen Targeted Therapies Market Other Major And Innovative Companies

31.1. Gilead Sciences Inc.

31.2. Amgen Inc.

31.3. Moderna Inc.

31.4. BioNTech SE

31.5. Bavarian Nordic Inc.

31.6. Advaxis Inc.

31.7. Immatics NV

31.8. Precision Biologics Inc.

31.9. Iovance Biotherapeutics Inc.

31.10. Agenus Inc.

31.11. Achilles Therapeutics Plc

31.12. Medigene AG

31.13. Gritstone Bio Inc.

31.14. SQZ Biotechnologies Company

31.15. Aduro BioTech Inc.

32. Global Neoantigen Targeted Therapies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neoantigen Targeted Therapies Market

34. Recent Developments In The Neoantigen Targeted Therapies Market

35. Neoantigen Targeted Therapies Market High Potential Countries, Segments and Strategies

35.1 Neoantigen Targeted Therapies Market In 2029 - Countries Offering Most New Opportunities

35.2 Neoantigen Targeted Therapies Market In 2029 - Segments Offering Most New Opportunities

35.3 Neoantigen Targeted Therapies Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Neoantigen Targeted Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Neoantigen Targeted Therapies Market, Sub-Segmentation Of Monotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Neoantigen Targeted Therapies Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Neoantigen Targeted Therapies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Neoantigen Targeted Therapies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: F. Hoffmann-La Roche AG Financial Performance

Table 79: Merck and Co. Inc. Financial Performance

Table 80: Bristol Myers Squibb Company Financial Performance

Table 81: Eli Lilly and Company Financial Performance

Table 82: Kite Pharma Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Neoantigen Targeted Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Neoantigen Targeted Therapies Market, Sub-Segmentation Of Monotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Neoantigen Targeted Therapies Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Neoantigen Targeted Therapies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Neoantigen Targeted Therapies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: F. Hoffmann-La Roche AG Financial Performance

Figure 79: Merck and Co. Inc. Financial Performance

Figure 80: Bristol Myers Squibb Company Financial Performance

Figure 81: Eli Lilly and Company Financial Performance

Figure 82: Kite Pharma Inc. Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Blood Cancer Drugs Global Market Report 2025 – By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan/Mabthera (Rituximab), Gleevec/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), Other Drugs), By Treatment Approaches (Key Findings, Chemotherapeutic, mAbs/Targeted Therapies, Immunotherapeutic) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer biologics Global Market Report 2025 – By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types), By Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers, Other Applications), By Distribution Channel (Hospitals, Clinics, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Rituximab Biosimilars Global Market Report 2025 – By Route Of Administration (Subcutaneous, Intravenous, Molecular Type), By Application (Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Other Applications), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Mail Order) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Acute Myeloid Leukemia Global Market Report 2025 – By Treatment Type (Chemotherapy, Radiation therapy, Stem Cell Transplant, Targeted Therapy), By Chemotherapy (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, Hormonal Therapy), By Regimen (DC Regimen, AVD Regimen, VCD Regimen), By End-User (Hospital, Retails Drug Stores, Ambulatory Care Centers, Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

CAR-T Therapy Global Market Report 2025 – By Type (Monotherapy, Combination Therapy), By Target Antigen (CD19, CD22, BCMA, Other Target Antigens), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Point-of-Care Diagnostics Devices And Equipment Global Market Report 2025 – By Type (Infectious disease testing kits, Cardio metabolic monitoring kits, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits, Other Types), By Prescription Mode (Prescription-based Testing Devices, Over-The-Counter (OTC) Testing Devices), By End User (Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Point-of-Care Diagnostics Devices And Equipment Global Market Report 2025 – By Type (Infectious disease testing kits, Cardio metabolic monitoring kits, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits, Other Types), By Prescription Mode (Prescription-based Testing Devices, Over-The-Counter (OTC) Testing Devices), By End User (Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2025 – By Product (Instrument, Reagent), By Technology (NASBA, HAD), By Application (Blood Screening, Infectious Disease Diagnostics, Cancer), By End-User (Hospital, Reference Laboratories, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Neoantigen Targeted Therapies market?

How will the Neoantigen Targeted Therapies market drivers and restraints affect the market dynamics? What forces will shape the Neoantigen Targeted Therapies industry going forward?

The Neoantigen Targeted Therapies market major growth driver - Rising Incidence Of Cancer Cases Drives Growth In The Neoantigen Targeted Therapies Market. For further insights on the Neoantigen Targeted Therapies market, request a sample here

What is the forecast market size or the forecast market value of the Neoantigen Targeted Therapies market?

The Neoantigen Targeted Therapies market size has grown strongly in recent years. The neoantigen targeted therapies market size has grown exponentially in recent years. It will grow from $3.4 billion in 2024 to $4.72 billion in 2025 at a compound annual growth rate (CAGR) of 38.7%. The growth in the historic period can be attributed to advancements in genomic sequencing, immunotherapy evolution, understanding tumor immunology, clinical success of checkpoint inhibitors, molecular profiling advancements The neoantigen targeted therapies market size is expected to see exponential growth in the next few years. It will grow to $16.01 billion in 2029 at a compound annual growth rate (CAGR) of 35.7%. The growth in the forecast period can be attributed to advancements in bioinformatics, precision medicine expansion, neoantigen vaccine development, therapeutic combination strategies, biomarker validation. Major trends in the forecast period include neoantigen resistance management, neoantigen-primed adoptive cell therapies, neoantigen-based combinatorial therapies, integration of real-world data, enhanced predictive models. For further insights on the Neoantigen Targeted Therapies market, request a sample here

How is the Neoantigen Targeted Therapies market segmented?

The neoantigen targeted therapies market covered in this report is segmented –
1) By Type: Monotherapy, Combination Therapy
2) By Immunotherapy Type: DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based Therapies
3) By Target Disease Indication: Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Bone Cancer, Gynecological Cancer
4) By Route Of Administration: Intradermal, Intravenous, Subcutaneous
5) By Application: Medical Research Institution, Hospital, And Clinic, Other Applications Subsegments:
1) By Monotherapy: Individual Neoantigen-Targeted Treatments
2) By Combination Therapy: Neoantigen-Targeted Therapies Combined With Other Immunotherapies, Neoantigen-Targeted Therapies Combined With Chemotherapy, Neoantigen-Targeted Therapies Combined With Targeted Therapies For further insights on the Neoantigen Targeted Therapies market, request a sample here

Which region has the largest share of the Neoantigen Targeted Therapies market? What are the other regions covered in the report?

North America was the largest region in the neoantigen targeted therapies market in 2024. The regions covered in the neoantigen targeted therapies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Neoantigen Targeted Therapies market, request a sample here.

Who are the major players in the Neoantigen Targeted Therapies market?

What are the key trends in the Neoantigen Targeted Therapies market?

Major trends in the Neoantigen Targeted Therapies market include Strategic Partnerships Drive Advancements In Personalized Neoantigen Targeted Cancer Therapies. For further insights on the Neoantigen Targeted Therapies market, request a sample here.

What are the major opportunities in the Neoantigen Targeted Therapies market? What are the strategies for the Neoantigen Targeted Therapies market?

For detailed insights on the major opportunities and strategies in the Neoantigen Targeted Therapies market, request a sample here.

How does the Neoantigen Targeted Therapies market relate to the overall economy and other similar markets?

For detailed insights on Neoantigen Targeted Therapies's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Neoantigen Targeted Therapies industry?

For detailed insights on the mergers and acquisitions in the Neoantigen Targeted Therapies industry, request a sample here.

What are the key dynamics influencing the Neoantigen Targeted Therapies market growth? SWOT analysis of the Neoantigen Targeted Therapies market.

For detailed insights on the key dynamics influencing the Neoantigen Targeted Therapies market growth and SWOT analysis of the Neoantigen Targeted Therapies industry, request a sample here.